Nutritional and Lifestyle Management in Polycystic Ovary Syndrome (Pcos)
DOI:
https://doi.org/10.63682/jns.v14i32S.7418Keywords:
Polycystic ovary syndrome (PCOS), nutrition, lifestyle management, exercise, yoga, probioticsAbstract
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 6-26% reproductive age women in the world. It is often associated with obesity, insulin resistance and various other metabolic impairment. Common treatment strategies include nutritional and lifestyle management along with pharmacological treatment. Studies have recommended that nutrition and exercise are key factors in the maintenance of health in women with PCOS. This narrative review aims to identify dietary and nutritional aspects of PCOS, role of nutritional supplements and exercise in prevention and treatment of PCOS in view of various studies. This will help to allow for an individual approach that will avoid unduly restrictive or nutritionally unbalanced diets.
Downloads
Metrics
References
Singh S, Pal N, Shubhan S, Sarma DK, Verma V, Marotta F and Kumar M. Polycystic ovary syndrome: Etiology, current management and future therapeutics. J Clin Med. 2023 Feb 11; 12(4): 1454. doi:10.3390/jcm12041454. PMID:36835989
Bremer AA. Polycystic ovary syndrome in the pediatric population. Metab. Syndr. Retal. Disorders.2010; 8: 375-394. doi:10.1089/met.2010.0039.
Herbert S and Woolf K. Moving beyond weight: A narrative review of the diet ary and lifestyle management for reducing cardiometabolic risk in polycystic ovary syndrome (PCOS). Nutrients.2023 Dec.11; 15(24): 5069. Doi: 10.3390/nu//15245069
Balen AH, Tan SL, MAC Dougall J, Jacobs HS. Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin. Hum. Reprod. 1993; 8: 959-964. doi:10.1093/oxfordjournals.humrep.a138174.
Urbanek M. The genetics of polycystic ovary syndrome. Natl Clin Pract Endocrinol Metab., 2007, 3:103-111.
Marx TL and Mehta AE. Polycystic ovary syndrome: Pathogenesis and treatmentover the short and long term. Cleve Clin J Med. 2003, 70(1):31-33, 36-41,45. [PubMed] [Google Scholar]
Dutta DC.2013. Textbook of Gynecology including contraception. 6th (Edn.),Chowkhambha Sanskrit Sansthan publishers, Varanasi, India.
Kutanaee MA, Amirjani S, Asemi Z, Taghavi S-A, Allan H, Kamalnadian S-N et al. The impact of depression, self-esteem and body image on sleep quality in patients with PCOS: a cross-sectional study. Sleep Breath. 2019; 1-8. Doi:10.1007/s11325-01946-9
Szczuko M, Kikut J, Szczuko U, Szydlowska I, Nawrocka- Rutkowska J, Zietek M, Verbanac D and Saso L. Nutrition strategy and lifestyle in polycystic ovary syndrome- Narrative review. Nutrients. 2021, 13:2452. https://doi.org/10.3390/nu13072452
Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what’s new? Adv Clin Exp Med. 2017; 26: 359-67.
Dalamaga M, Papadavid E, Basios G, Vaggopoulos V, Rigopoulos D, Kassanos D, Trakakis E. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. J Am Acad Dermatol. 2013; 69(6): 922-30. https://doi.org/10.1016/j.jaad.2013.09.014. Epub2013 Oct 11 PMID: 24120563
Zeind CS, Carvalho MG. Applied Therapeutics: the clinical use of drugs; Wolters Kluwer Health: Philadelphia. USA:PA; 2017
Lorenzo Md, Cacciapuoti N, Lonardo MS, Nasti G, Guatiero C, Belfiore A, Guida B and Chiurazzi M. Pathophysiology and nutritional approaches in polycystic ovary syndrome (PCOS): A comprehensive review. Current Nutrition Reports, 2023; Vol 12: 527-544. doi:https://link.springer.com/article/10.1007/s13668-023-00479-8
Rajbanshi I, Sharma VK, Tuladhar ET, Bhattarai A, Raut M, Dubey RK, Koirala P, Niraula A. Metabolic and biochemical profile in women with polycystic ovarian syndrome attending tertiary care centre of central NEPAL. BMC Womens Health. 2023 Apr 28;23(1):208. doi:10.1186/s12905-023-02379-z. PMID:37118753; PMCID:PMC10148396
Del Pup L, Cagnacci A. Improve lifestyle in polycystic ovary syndrome: A systematic strategy. Gynecol Endocrinol. 2021:1-4. doi:10.1080/09513590.2021.1871892.
Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al.Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33(9): 1602-1618. doi:10.1093/humrep/dey256.
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, Costello MF, Boivin J, Redman LM, Boyle JA, et al. Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J. Clin. Endocrinol. Metab. 2023, 108,2447-2469. [Google Scholar] [Cross Ref] [PubMed]
Stracquadanio M, Ciotta L. PCOS therapy. In: Stacquadanio M, Ciotta L, editors. Metabolic Aspects of PCOS: Treatment with Insulin Sensitizers. 2015. Cham: Springer International Publishing; pp. 89-137.
Farshchi H, Rane A, Love A, Kennedy RL. Diet and nutrition in polycystic ovary syndrome(PCOS): pointers for nutritional management. J Obstet Gynaecol. 2007 Nov; 27(8): 762-73. doi:10.1080/01443610701667338
Faghfoori Z, et al. Nutritional management in women with polycystic ovary syndrome: A review study. Diab Met Syndr: Clin Res Rev. 2017. http://dx.doi.org/10.1016/j.dsx.2017.03.030
Hoeger K. Obesity and weight loss in polycystic ovary syndrome (PCOS). Obstet Gynecol Clin North Am. 2001. 28(1): 85-97 vi-vii.
Martinez-Bermijo E, Luque- Ramirez M, Escobar- Morreale HF. Obesity and the polycystic ovary syndrome. Minerva Endocrinol. 2007;32(3): 129-40.
Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G. Obesity, weight loss and the polycystic ovary syndrome: effect of treatment with diet and or listat for 24 weeks on insulin resistance and androgen levels. Fertil Steril. 2008; 89(4): 899-906.
Franks S, Kiddy DS, Hamilton- Fairley D, Bush A, Sharp PS, Reed MJ. The role of nutrition and insulin in the regulation of sex hormone binding globulin, J Steroid Biochem. Mol. Biol. 1991; 39: 835-838. doi:10.1016/0960-0760(91)90033-2.
Tymchuk CN, Tessler SB, Barnard RJ. Changes in sex hormone- binding globulin, insulin and serum lipids in postmenopausal women on a low-fat, high fiber diet combined with exercise. Nutr. Cancer. 2000; 38: 158-162. doi:10.1207/s15327914 NC382_3.
Georgopoulos NA, Saltamavros AD, Vervita V, Karkoulias K, Adonakis G, Decavalas G, et al. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance. Fertile Steril. 2009; 92(1): 250-5.
Xenou M and Gourounti K. Dietary patterns and polycystic ovary syndrome: A systematic review. Maedica (Bucur). 2021 Sep: 16(3): 516-521. doi:10.26574/maedica.2020.16.3.516
Yang J, Liang J, Xu J, Lin T, Ye Q, Lin Q, Ji F and Shi D. The impact of dietary interventions on polycystic ovary syndrome patients with a BMI>25kg/m2: A systematic review and meta-analysis of randomized controlled trials. Reprod Med Biol. 2024 Sep 30; 23(1): e12607. doi:10.1002/rmb2.12607. PMID:39351128; PMCID: PMC11442045
Darand M, Sadeghi N, Salimi Z, Nikbaf- Shandiz M, Panjeshahin A, Fateh HL, Hosseinzadeh M. Is the MIND diet useful for polycystic ovary syndrome? A case study. BMC Women Health. 2024 May 9; 24(1): 282. doi:10.1186/s12905-024-03090-3. PMID:38724955; PMCID: PMC11084111.
Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS). Nutrients. 2019; 11:2278. doi: 10.3390/nu11102278
Kazemi M, Jarrett BY, Vanden Brink H, et al. Obesity, insulin resistance and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women. Nutrients. 2020; 12: 1953. doi:10.3390/nu12071953
Paoli A, Mancin L, Giacona MC, et al. Effects of a ketogenic diet in overweight women with polycystic ovary syndrome. Journal of Translational Medicine. 2020; 18: 104. doi:10.1186/s12967-020-02277-0.
Schishehgar F, Mirmiran P, Rahmati M, Tohidi M, Ramezani Tehrani F. Does a restricted energy low glycemic index diet have a different effect on overweight women with or without polycystic ovary syndrome? BMC Endocr. Disord. 2019, 19, 93. [Cross Ref]
Calcaterra V, Magenes VC, Massini G, De Sanctis L, Fabiano V, Zuccotti G. High fat diet and polycystic ovary syndrome (PCOS) in adolescence: An overview of nutritional strategies. Nutrients, 2024 Mar 24; 16(7): 938. doi:10.3390/nu16070938. PMID: 38612972; PMCID: PMC11013055.
Jakubowicz D, Barnea M, Wainstein J, Froy O. High caloric intake at breakfast vs. dinner differentially influences weight loss of overweight and obese women. Obesity (Silver Spring). 2013; 21(12):2504-12.
Papakonstantinou E, kechribari I, Mitrou P, Trakakis E, Vassiliadi D, Georgousopoulou E, et al. Effect of meal frequency on glucose and insulin levels in women with polycystic ovary syndrome: a randomized trial. Eur J Clin Nutr. 2016; 70(5):588-94.
Kulshreshtha B, Sharma N, Pant S, Sharma L, Pahuja B, Singh P. PCOS patients differ in meal timings rather than total caloric or macronutrient intake in comparison to weight matched controls. Eur J Obstet Gynecol Reprod Biol. 2022 Mar; 270: 11-16. doi:10.1016/j.ejogrb.2021.12.023.Epub 2022 Jan 4. PMID: 35007973
Eleftheriadou M, Stefanidis K, Lykeridou K and Iliadis I. Dietary habits in adolescent girls with polycystic ovary syndrome. Gynecological Endocrinology 2014 Nov 31(4): 1-3. Doi: 10.3109/09513590.2014.984677.
Kolnikaj TS, Herman R, Andrej J and Jensterle M. Assessment of eating disorders and eating behaviour to improve treatment outcomes in women with pol ycystic ovary syndrome. Life (Basel). 2022 Nov 16; 12(11); 1906. doi:10.3390/life12111906. PMCID: PMC9692921
Neves LPP, Marcondes RR, Maffazioli GDN, Simoes RS, Maciel GAR, Soares JM, et al. Nutritional and dietary aspects in polycystic ovary syndrome: Insights into the biology of nutritional interventions. Gynecological Endocrinology. 2020; 36(12): 1047-1050.
Moran LJ, Brinkworth GD, Norman RJ. Dietary therapy in polycystic ovary syndrome. Semin Reprod Med 2008; 26(1):85-92.
Papavasiliou K, Papakonstantinou E. Nutritional support and dietary interventions for women with polycystic ovary syndrome. Nutrition and Dietary Supplements. 2017; 9: 63-85.
Pandey M and Niroula K. Optimizing nutrition for PCOS management: A comprehensive guide. In book: Polycystic Ovary Syndrome_ Symptoms, Causes and Treatment. DOI: 10.5772/intechopen.114149
Rizkalla SW, Taghrid L, Laromiguiere M, Huet D, Boillot J, Rigoir A, et al. Improved plasma glucose control, whole-body glucose utilization and lipid profile on a low-glycemic index diet in type 2 diabetic men: a randomized controlled trial. Diab Care; 27(8):1866-72.
Ebbeling CB, Leidig MM, Sinclair KB, Seger-Shippee LG, Feldman HA, Ludwig DS. Effects of an ad libitum low-glycemic load diet on cardiovascular disease risk factors in obese young adults. Am J Clin Nutr 2005; 81(5):976-82.
Brynes AE, Mark Edwards C, Ghatei MA, Dornhorst A, Morgan LM, Bloom SR, et al. A randomized four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. Br J Nutr 2003; 89(2):207-18.
Leung WT, Tang Z, Feng Y, Guan H, Huang Z, Zhang W. Lower fiber consumption in women with polycystic ovary syndrome. A meta-analysis of observational studies. Nutrients. 2022 Dec 12; 14(24):5285. doi:10.3390/nu14245285. PMID:36558444; PMCID:PMC9785338.
Cowan S, Lim S, Alycia C, et al. Lifestyle management in polycystic ovary syndrome-beyond diet and physical activity. BMC Endocr Disord. 2023; 23, 14. Neves LPP, Marcondes RR, Maffazioli GDN, Simoes RS, Maciel GAR, Soares JM, et al. Nutritional and dietary aspects in polycystic ovary syndrome: Insights into the biology of nutritional interventions. Gynecological Endocrinology. 2020; 36(12): 1047-1050.
https://doi.org/10.1186/s12902-022-01208-y
Parker DR, Weiss ST, Troisi R, Cassano PA, Vokonas PS, Landsberg L. Relationship of dietary saturated fatty acids and body habits to serum insulin concentrations: the Normative Aging Study. Am J Clin Nutr: 58(2):129-36.
Stender S, Dyerberg J. Influence of trans fatty acids on health. Ann Nutr Metab. 2004; 48(2):61-6.
Esmaeilzadeh S, Gholinezhad-Chari M, Ghadimi R. The effect of metformin treatment on the serum levels of homocysteine, folic acid and vitamin B12 in patients with polycystic ovary syndrome. Journal of Human Reproductive Sciences. 2017; 10(2):95-101.
Eslamian G and Hekmatdoost. Nutrient patterns and risk of polycystic ovary syndrome. J Reprod Infertil. 2019 Jul-Sep; 20(3):161-168. PMID:31423419
Brilliant A, Astuti BPK, Joyo FO, Febri RR. Vitamin B3(niacin), B^, C and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome. Journal of the Turkish German Gynecological Association 2022, 23(3), 130.
Shoaibinobarian N, Ghazaleh E, Noormohammadi M, Shirin M, Shayesteh R, Seyedeh NM. Dietary total antioxidant capacity and risk of polycystic ovary syndrome: A case-control study. Int J Fertil Steril.2022 Aug 21; 16(3):200-205. doi:10.22074/IJFS.2021.526579.1107
Sunar F, Baltaci AK, Ergene N, Mogulkoc R. Zinc deficiency and supplementation in ovariectomized rats: Their effect on serum estrogen and progesterone levels and their relation to calcium and phosphorus. Pakistan Journal of Pharmaceutical Sciences. 2009; 22(2):150-154.
Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbicer HC. 2013. Plasma selenium levels in Turkish women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol; 168(2): 183-186.
Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PW, Jacques PF. 2006. Magnesium intake is related to improved insulin homeostasis in the Framingham offspring cohort. J Am Coll Nutr; 25(6):486-92.
Lervolino M, Lepore E, Forte G, Lagana AS, Buzzaccarini G, Unfer V. Natural molecules in the management of Polycystic ovary syndrome(PCOS): An analytical review. Nutrients. 2021; 13(5):1677.
Chen J, Guo Q, Pei IH, Ren QL, Chi L, Hu RK, et al. Effects of a short-term vitamin E supplementation on oxidative stress in infertile PCOS women under ovulation induction: A retrospective cohort study. BMC Women’s Health. 2020;20(1):69.
Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2012; 77: 343-50. doi:10.1111/j.1365-2265.2012.04434.x.
Mohan A, Haider R, Fakhor H, Hina F, Kumar V, Jawed A, Mujumder K, Ayaz A, Priyanka ML, Tejwaney U, Ram N, Kazeem S. Vitamin D and polycystic ovary syndrome (PCOS): a review. Ann Med Surg (Lond). 2023 Jun 5; 85(7):3506-3511. doi:10.1097/MS9.0000000000000879. PMCID:PMC10328709 PMID:37427232
Shen JY, Xu L, Ding Y, Wu XY. Effect of vitamin supplementation on polycystic ovary syndrome and key pathways implicated in its development: A Mendelian randomization study. World J Clin Cases. @023 Aug 16; 11(23):5468-5478. doi:10.12998/wjcc.v11.i23.5468
Vindhya M, Bhumika S, Mythreyi R, Murugesan K, et al. Role of vitamin A and vitamin D in management of polycystic ovary syndrome. Journal of Medicine and Health Sciences Research. Vol.6 Dec.2023, pp. 7-11. Doi:10.21839/jmhsr.2023.v6.8730
Tahaei LS, Eimani H, Yazdi PE,Ebrahimi B and Fathi R.Effects of retinoic acid on maturation of immaturemouse oocytesin the presence and absence of a granulosa cell co-culture system.Journal of Assisted Reproductionand Genetics. 2011, 28,553-558. https://doi.org/10.1007/s10815-011-9579-8
Pu Y, Wang Z, Bian Y, Zhang F, Yang P, Li Y, Zhang Y, Liu Y, Fang F, Cao H and ZhangX. All-trans retinoic acid improves goat oocyte nuclear maturation and reduces apoptoticcumuluscells during in vitro maturation. Animal Science Journal. 2014 85(9), 833-839. https://doi.org/10.1111/asj.12216
Nowak DA, Snyder DC, Brown AJ, Demark- Wahnefried W. The effect of Flaxseed supplementation on hormonal levels associated with polycystic ovarian syndrome: A case study. Current Topics in Nutraceutical Research.2007: 5(4):177-181.
Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, MahmoodiS, Taghizadeh M, et al. The effects of flaxseed oil Omega-3 fatty acids supplementation on metabolicstatus of patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Experimental and Clinical Endocrinology &Diabetes: OfficialJournal, GermanSociety of Endocrinology [and] German DiabetesAssociation.2018;126(4):222-228
Hajimonfarednejad M, Nimrouzi M, Heydari M, Zarshenas MM, Raee MJ, Jahromi BN. Insulin resistance improvement by cinnamon powder in polycysticovary syndrome: A randomized double-blind placebo controlled clinical trial. Phytotherapy Research. 2018;32(2):276-283
Calcaterra V, Rossi V, Massini G, Casini F, ZuccottiG, Fabiano V. Probiotics and Polycystic ovary syndrome: A perspective for management in adolescents with obesity. Nutrients. 2023 Jul 14;15(14):3144. doi:10.3390/nu15143144. PMID:37513562; PMCID:PMC10384396.
Ahmadi S, Jamilian M, Karamali M, Tajabadi- Ebrahimi M, Jafari P, Taghizadeh M, Memarzadeh MR, Asemi Z. Probiotic supplementation and the effects on weight loss, glycaemia and lipid profiles in women with polycystic ovary syndrome: A randomized double-blind, placebo-controlled trial. Hum Fertil. 2017; 20:254-61.
Shamasbi SG, Ghanbari-Homayi S, Mirghafourvand M. The effect of probiotics, prebiotics and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Nutr. 2020; 59;433-50
Shamasbi SG, Dehgan P, Mohammed- Alizadeh CS, Aliasgarzadeh A, Mirghafourvand M. The effect of resistant dextrin as a prebiotic on metabolic parameters and androgen level in women with polycystic ovarian syndrome: a randomized, triple-blind, controlled, clinical trial. Eur J Nutr. 2019;58:629-40
Patten RK, Boyle RA, Moholdt T, Kiel I, Hopkins WG, Harrison CL, Stepto NK. Exercise interventions in polycystic ovary syndrome: A systematic review and meta-analysis. Front. Physiol. 2020, 11,606
Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. J. Funct. Morphol. Kinesiol. 2020,5,35.
Monro R. Yoga therapy. J Bodyw Mov Ther. 1997;1(4):215-218. doi:10.1016/s1360-8592(97)80047-2.
Patel V., Menezes H., Menezes C. Bouwers and Chevelta A. Regular mindful yoga practice as a method to improve androgen levels in women with polycystic ovary syndrome: A randomized, controlled trial. Journal of Osteopathic medicine.2020 120(5): 323-335.
Kumari D, Kumar M, Tiwari P, Mahey R, Malhotra N, Mishra R and Dada R. Impact of Yoga in polycystic ovary syndrome. International Journal of Ayurveda Research. 2023 Vol. 4(3):132-136.
Nidhi R., Padmalatha V., Nagarathna R., and Amritanshu R. 2013. Effects of a holistic yoga program on endocrine parameters in adolescents with polycystic ovarian syndrome: A randomized controlled trial. The Journal of Alternative and Complementary Medicine 19(2):153-160
Nidhi R, Padmalatha V, Nagarathna R and Amritanshu R.2013. Effect of Yoga program on quality of life in adolescent polycystic ovarian syndrome randomised control trial. Applied Research in quality of life 8, 373-383
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
